BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2017 12:23:13 AM | Browse: 999 | Download: 1854
 |
Received |
|
2017-04-07 14:39 |
|
Peer-Review Started |
|
2017-04-10 16:31 |
|
To Make the First Decision |
|
2017-05-10 17:25 |
|
Return for Revision |
|
2017-05-19 07:00 |
|
Revised |
|
2017-07-14 17:02 |
|
Second Decision |
|
2017-08-25 07:34 |
|
Accepted by Journal Editor-in-Chief |
|
2017-08-25 08:54 |
|
Accepted by Executive Editor-in-Chief |
|
2017-09-04 03:26 |
|
Articles in Press |
|
2017-09-04 03:26 |
|
Publication Fee Transferred |
|
2017-09-25 03:00 |
 |
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-10-25 01:51 |
|
Publish the Manuscript Online |
|
2017-10-27 00:23 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiaoping He, Lynne Hopkins, George Everett, Willie M Carter, Cynthia SchroppDyce, Khalid Abusaada and Vincent Hsu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiaoping He, MD, PhD, The Internal Medicine Residency Program of Florida Hospital, 2501 North Orange Ave, Suite 235, Orlando, FL 32804, United States. xiaoping.he.md@flhosp.org |
| Key Words |
Hepatitis C; Human immunodeficiency virus; Ledipasvir; Sofosbuvir |
| Core Tip |
This is a retrospective study to evaluate the safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in patients with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection in an urban HIV clinic. It demonstrated the high rates of SVR12 of ledipasvir/sofosbuvir on HCV eradication in patients co-infected with HCV and HIV, regardless of HCV baseline levels, HCV treatment history or cirrhosis condition. The oral combination of ledipasvir/sofosbuvir represents a safe and well tolerated HCV treatment option that does not require modification for many of the common HIV antiretroviral therapy (ART). Occasional HIV virologic rebound occurred but later resolved without the need to change ART. |
| Publish Date |
2017-10-27 00:23 |
| Citation |
He X, Hopkins L, Everett G, Carter WM, SchroppDyce C, Abusaada K, Hsu V. Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients. World J Hepatol 2017; 9(30): 1190-1196 |
| URL |
http://www.wjgnet.com/1948-5182/full/v9/i30/1190.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v9.i30.1190 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
